Figure 1
ATHA Energy Completes Angilak Project Equipment and Supply Mobilization, Update on Commencement of Diamond Drilling
30 avr. 2024 07h00 HE | ATHA Energy Corp.
HIGHLIGHTS: The Company has completed its equipment and supply mobilization to its 100%-owned Angilak Project in Nunavut, Canada.Mobilization included the delivery of two X10 Diamond Drills (Tactex...
Athira Pharma Logo RGB@1200px.jpg
Athira Pharma Appoints Javier San Martin, M.D., as Chief Medical Officer
15 avr. 2024 07h00 HE | Athira Pharma, Inc.
Athira Pharma Appoints Javier San Martin, M.D., as Chief Medical Officer.
Figure 1
ATHA Energy Provides Update on 2024 Exploration Program
20 mars 2024 07h00 HE | ATHA Energy Corp.
2024 EXPLORATION PROGRAM HIGHLIGHTS & UPDATE TO 92 ENERGY TRANSACTION: ATHA begins the Company’s most significant exploration program to date, targeting Canada’s most prospective regions for...
ATHA_logo.png
ATHA Energy Announces Latitude Uranium Obtains Shareholder Approval for Transaction
28 févr. 2024 07h00 HE | ATHA Energy Corp.
VANCOUVER, British Columbia, Feb. 28, 2024 (GLOBE NEWSWIRE) -- ATHA Energy Corp. (CSE: SASK) (FRA: X5U) (OTCQB: SASKF) (“ATHA”) is pleased to announce that shareholders (“LUR Shareholders”) of...
ATHA_logo.png
ATHA Energy Announces Appointment of Ryan Gaffney as Senior Vice President, Business Development
27 févr. 2024 07h00 HE | ATHA Energy Corp.
VANCOUVER, British Columbia, Feb. 27, 2024 (GLOBE NEWSWIRE) -- ATHA Energy Corp. (CSE: SASK) (FRA: X5U) (OTCQB: SASKF) (“ATHA” or the “Company”), holder of the largest uranium exploration portfolio...
ATHA_logo.png
ATHA Energy Provides Further Updates to Transaction With 92 Energy
21 févr. 2024 07h00 HE | ATHA Energy Corp.
VANCOUVER, British Columbia, Feb. 21, 2024 (GLOBE NEWSWIRE) -- ATHA Energy Corp. (CSE: SASK) (FRA: X5U) (OTCQB: SASKF) (“ATHA”) is pleased to provide another update on its previously announced...
ATHA_logo.png
ATHA Energy Announces Appointment of Cliff Revering as Vice President Exploration and Karina Tyne as Director of Corporate Affairs
12 févr. 2024 07h00 HE | ATHA Energy Corp.
VANCOUVER, British Columbia, Feb. 12, 2024 (GLOBE NEWSWIRE) -- ATHA Energy Corp. (CSE: SASK) (FRA: X5U) (OTCQB: SASKF) (“ATHA” or the “Company”), holder of the largest uranium exploration portfolio...
ATHA_logo.png
ATHA Energy Provides Further Updates to Transactions With 92 Energy and Latitude Uranium
07 févr. 2024 07h00 HE | ATHA Energy Corp.
HIGHLIGHTS ATHA has successfully obtained executed resolutions approving the Transactions (as defined below) from shareholders of ATHA holding greater than 50% of the issued and outstanding common...
image2.jpeg
ATHA Energy Discovers High-Priority Electromagnetic Target Coincident With 11.3% U308 Boulder Sample
31 janv. 2024 07h00 HE | ATHA Energy Corp.
NORTH BEACON AND NORTH CREST PROJECT HIGHLIGHTS Uriniferous boulder train discovered on the North Beacon Project – with grades of up to 11.3% U3O8 – analysis of the boulder train ice direction show...
Athira Pharma Logo RGB@1200px.jpg
Athira Pharma Announces Encouraging Results from SHAPE Phase 2 Clinical Trial of Fosgonimeton for the Treatment of Parkinson's Disease Dementia and Dementia with Lewy Bodies
12 déc. 2023 07h00 HE | Athira Pharma, Inc.
Exploratory findings add to increasing body of clinical and preclinical data supporting positive modulation of the neurotrophic HGF system as a potential therapeutic approach for neurodegenerative...